Abstract
BIOCHEMICAL and immunological methods of distinguishing between normal and malignant cells have had limited success. When studying cellular transformation, it is advantageous to study tumour viruses since they contain a definable quantity of genetic information for viral replication and for cell transformation. Viral gene products, such as viral structural antigens, can be studied in both normal infected and virus-transformed cells. Oncornavinis antigens are found in the cytoplasm and cell membrane of both normal and transformed infected cells1,2. These antigens are glycoproteins of the viral envelope or are internal viral proteins3–5. Non-viral tumour-specific antigens resulting from transformation of the host cell by the causative virus, are found in the tumour cell membrane of some tumours induced experimentally by polyoma6 and SV407 DNA viruses; and in cells transformed by an oncornavirus, the Rous sarcoma virus8,9, but have not yet been found in any oncornavirus-induced leukaemic cell. Lymphosarcoma (LSA) or leukaemia of pet cats is caused by a contagiously spread oncornavirus, the feline leukaemia virus (FeLV)10. Antibody to the feline oncornavirus-associated cell membrane antigen (FOCMA)11,12 is associated with resistance to LSA development in FeLV-infected pet cats13,14 and with regression of feline sarcoma virus (FeSV) experimentally-induced fibrosarcomas15. To determine whether FOCMA is a tumour-specific antigen, we tested normal, LSA and fibrosarcoma cat cells for both FeLV antigens and FOCMA. We report here that FOCMA is a tumour-specific antigen induced by naturally occurring feline leukaemia and sarcoma viruses. Our observation, which was made in a random bred species, the pet cat, may have particular relevance for the diagnosis and therapy of naturally occurring lymphoid tumours of other animals, including man.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Klein, G. Fedn Proc. 28, 1739–1753 (1969).
Old, L. J. & Boyse, E. A. A. Rev. Med. 15, 167–186 (1964).
Hardy, W. D. Jr et al. Science 166, 1019–1021 (1969).
Yoshiki, T., Mellors, R. C. & Hardy, W. D. Jr Proc. natn. Acad. Sci. U.S.A. 70, 1878–1882 (1973).
Yoshiki, T., Mellors, R. C., Hardy, W. D. Jr & Fleissner, E. J. exp. Med. 139, 925–942 (1974).
Habel, K. Fedn Proc. 22, 438 (1963).
Girardi, A. J. Proc. natn. Acad. Sci. U.S.A. 54, 445–451 (1965).
Kurth, R. & Bauer, H. Virology 49, 145–159 (1972).
Gelderblom, H., Bauer, H. & Graf, T. Virology 47, 416–425 (1972).
Hardy, W. D. Jr, Old, L. J., Hess, P. W., Essex, M. & Cotter, S. Nature 244, 266–269 (1973).
Essex, M., Klein, G., Snyder, S. P. & Harrold, J. B. Nature 233, 195–196 (1971).
Essex, M. in Adv. Cancer Res. 21 (ed Klein, G. & Weinhouse, S.) 175–248 (Academic, New York, 1975).
Essex, M., Sliski, A., Cotter, S. M., Jakoswki, R. M. & Hardy, W. D. Jr, Science 190, 790–792 (1975).
Hardy, W. D. Jr et al. Cancer Res. 36, 582–588 (1976).
Essex, M., Klein, G., Snyder, S. P. & Harrold, J. B. Int. J. Cancer 8, 384–390 (1971).
Hardy, W. D. Jr, Hirshaut, Y. & Hess, P. in Unifying Concepts of Leukaemia (eds Dutcher, R. M. & Chieco-Bianchi, L.) 778–799 (Karger, Basel, 1973).
Taylor, D., Hokania, Y. & Perri, S. F. J. Immun. 115, 862–865 (1976).
Essex, M., Cotter, S. M., Stephenson, J. R., Aaronson, S. A. & Hardy, W. D. Jr in Origins of Human Cancer (ed Hiatt, H. H., Watson, J. D. & Winston, J. A.) (Cold Spring Harbor Laboratories, New York, in the press).
Stephenson, J. R., Essex, M., Hino, S., Hardy, W. D. Jr & Aaronson, S. A. Proc. natn. Acad. Sci. U.S.A. 74, 1219–1223 (1977).
Sliski, A. H., Essex, M., Meyer, C. & Todaro, G. Science 196, 1336–1339 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
HARDY, W., ZUCKERMAN, E., MACEWEN, E. et al. A feline leukaemia virus- and sarcoma virus-induced tumour-specific antigen. Nature 270, 249–251 (1977). https://doi.org/10.1038/270249a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/270249a0
This article is cited by
-
Immunophenotypic analysis of feline haemolymphatic neoplasia using flow cytometry
Comparative Haematology International (1995)
-
Characterization of a newly established feline lymphoma-derived cell line (BKD) lacking T and B cell surface markers
In Vitro Cellular & Developmental Biology (1986)
-
Reactivation of latent feline leukaemia virus infection
Nature (1982)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.